PRESS RELEASE, 2006-05-22

Ludesi Announces Mitsubishi Pharma Corporation Sign Agreement on 2D Gel Image Analysis

 
Lund, Sweden - May 22, 2006 -- Ludesi AB, a rapidly growing bioinformatics company modernizing image and data analysis processes in proteomics, today announced that Mitsubishi Pharma in Yokohama, Japan after thorough testing has selected Ludesi for its image analysis processing of 2D gels.
 
Mitsubishi Pharma Corporation has contracted Ludesi for image analysis of two-dimensional protein gels (2D gels), one of the fundamental technologies in proteomics. Ludesi's offering was chosen over other software systems due to its high level of quality and reproducibility. Ludesi offers 2D gel image analysis as a service through a web-based user-friendly software that can be accessed by scientists securely from anywhere in the world.
 
"-We are proud that Mitsubishi Pharma has selected Ludesi's technology for 2D gel image analysis, and we look forward to working together in the years to come" commented Ludesi's CEO Ola Forsstrom-Olsson. "It is an honor to serve Mitsubishi Pharma's skilled scientists with top-notch quality in this important proteomics technology."
 
Experts at Mitsubishi Pharma Corporation tested Ludesi's system thoroughly and concluded that Ludesi's offering provided an increased quality and reliability compared to other software systems on the market.
 

About Mitsubishi Pharma Corporation

Mitsubishi Pharma Corporation, a research-driven pharmaceutical company, is the core member in the Mitsubishi Chemical Holdings group, under which Mitsubishi Chemical,a leading chemical company in Japan, and Mitsubishi Pharma exist as wholly subsidiaries. The company is committed to scientific progress, pharmaceutical advancement and the creation of products that benefit people's welfare worldwide. Its core therapeutic areas are psychiatric and central nervous system diseases, cardiovascular and metabolic diseases, immunological and respiratory diseases, and hepatic diseases. More information about the company can be found by visiting www.m-pharma.co.jp
 
For further information please contact:
 
Ola Forsstrom-Olsson, CEO, Ludesi
Phone: +46-46-286-5510
Mobile: +46-70-812-2548
E-mail: ola.forsstrom-olsson@ludesi.com